Cassava Sciences reported $-0.21 in EPS Earnings Per Share for its fiscal quarter ending in March of 2026.





Eps Change Date
Abbott USD 1.31 0.16 Jun/2026
Amgen USD 6.29 1.14 Jun/2026
Biogen USD 3.6 0.03 Jun/2026
Cara Therapeutics USD -0.72 0.14 Mar/2026
Cassava Sciences USD -0.21 0.05 Mar/2026
Eisai JPY 64.71 76.24 Jun/2026
Eli Lilly USD 8.38 0.17 Jun/2026
Geron USD -0.02 0.01 Jun/2026
J&J USD 2.9 0.2 Jun/2026
Merck USD -0.13 1.15 Jun/2026
Novartis USD 2.41 0.42 Jun/2026
Novavax USD 0.13 0.59 Dec/2025
Pfizer USD 0.77 0.02 Jun/2026
Roche Holding CHF 10.98 2.61 Jun/2026